US 7858583
Process for purifying glycopeptide phosphonate derivatives
granted A61PA61P31/04
Quick answer
US patent 7858583 (Process for purifying glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P31/04